David K. Yang (@davidkmyang) 's Twitter Profile
David K. Yang

@davidkmyang

Life sciences @Lux_Capital. Prev: Co-founder of Latus Bio, Investor at 8VC, Comp bio at Broad Institute

ID: 1039013423609204736

calendar_today10-09-2018 04:51:18

293 Tweet

2,2K Followers

1,1K Following

David K. Yang (@davidkmyang) 's Twitter Profile Photo
David K. Yang
@davidkmyang

4 months ago

Pharmas typically acquire drugs they know how to commercialize. This means assets that are trickier to commercialize, e.g. drug+device combos, can be overlooked due to low M&A interest. What are other therapeutics classes with similar dynamics, but nonetheless promising?